Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Semapa Next
Portugal
- Lisboa
- 10/11/2022
- Unknown
- $5,500,000
Semapa Next is a venture capital firm that invests in teams of exceptional founders from Series A to late-stage funding. We support today the leaders of tomorrow. From Lisbon to Europe.
We want to be a long-term partner of exceptional teams that are positively changing the world we live in. Besides investing with patient capital, we bring a mix of entrepreneurial, operational, and financial experience to our investments.
Our team and network of advisors has direct experience in Sales & Marketing, Talent Management, Finance, and M&A with businesses across all stages of development.
We provide access to Semapa’s Group and its international network of partners to leverage opportunities of business development, technology piloting and world-class expertise in managing and growing global businesses.
- Industry Venture Capital and Private Equity Principals
- Website https://semapanext.com/
- LinkedIn https://www.linkedin.com/company/semapanext/
Related People
Ricardo PiresFounder
Portugal -
Lisbon, Lisbon,
Experienced Board Member with a demonstrated history of working in the investment management industry. Skilled in Negotiation, Business Planning, Venture Capital, Acquisitions, and Capital Markets. Strong business development professional with a Pevc focused in Private equity and venture capital from Harvard Business School.
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)